Trial intelligence / Profile preview

ASPIRE: Crisaborole and Tacrolimus in Children with Atopic Dermatitis

NCT03645057Phase 3Completed

Sponsor
University of Rochester
Start
Feb 2019
Primary completion
Aug 2021
Countries
1
01

Overview

A Phase 3 trial of AN2728 ointment vehicle in atopic dermatitis (AD), sponsored by University of Rochester. Started Feb 2019; status: completed.

02

Drugs

AN2728 ointment vehicle
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT03645057.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03645057.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call